Corrigendum: Safety issues of tirzepatide (pancreatitis and gallbladder or biliary disease) in type 2 diabetes and obesity: a systematic review and meta-analysis.

Zeng, Qingyue; Xu, Jiao; Mu, Xingyu; Shi, Yi; Fan, Hong; Li, Shuangqing

Zeng, Qingyue; Xu, Jiao; Mu, Xingyu; Shi, Yi; Fan, Hong; Li, Shuangqing.

Afiliación

Zeng Q; General Practice Ward/International Medical Center Ward, General Practice Medical Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Xu J; General Practice Ward/International Medical Center Ward, General Practice Medical Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Mu X; General Practice Ward/International Medical Center Ward, General Practice Medical Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Shi Y; General Practice Ward/International Medical Center Ward, General Practice Medical Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Fan H; Department of Pulmonary and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China.
Li S; General Practice Ward/International Medical Center Ward, General Practice Medical Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Front Endocrinol (Lausanne) ; 15: 1342543, 2024.

Article en En | MEDLINE | ID: mdl-38549766

ABSTRACT

ABSTRACT

[This corrects the article DOI 10.3389/fendo.2023.1214334.].

Palabras clave

dual agonists; glucagon-like peptide-1 receptor agonists; incretin based therapy; obesity; tirzepatide; type 2 diabetes

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Endocrinol (Lausanne) Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google